What is Crohn's & Colitis Foundation?
Established in 1967 by visionaries Irwin M. and Suzanne Rosenthal, William D. and Shelby Modell, and Henry D. Janowitz, M.D., the Crohn's & Colitis Foundation operates as a volunteer-driven, non-profit entity. Its primary mission is twofold: to discover definitive cures for Crohn's disease and ulcerative colitis, and to enhance the daily lives of those navigating these chronic conditions. By bridging the gap between clinical research and patient support, the foundation maintains a critical role in the healthcare ecosystem, providing essential resources for both pediatric and adult populations affected by these debilitating illnesses.
The organization's operational model relies on a sophisticated network of researchers, medical professionals, and dedicated volunteers. Through its strategic deployment of funds, the foundation supports high-impact clinical trials, educational initiatives, and advocacy programs that influence public health policy. Its market position is defined by its longevity and its ability to mobilize significant philanthropic and institutional support to drive scientific progress in gastroenterology.
How much funding has Crohn's & Colitis Foundation raised?
Crohn's & Colitis Foundation has raised a total of $7M across 2 funding rounds:
Debt
$5M
Debt
$2M
Debt (2020): $5M with participation from PPP
Debt (2021): $2M led by PPP
Key Investors in Crohn's & Colitis Foundation
PPP
Public-Private Partnership
What's next for Crohn's & Colitis Foundation?
Looking ahead, the foundation is poised to utilize its recent capital injection to scale its research pipeline and expand its patient support infrastructure. The strategic focus will likely center on precision medicine and the development of novel therapeutic interventions that address the underlying mechanisms of inflammatory bowel disease. By prioritizing data-driven research and collaborative partnerships, the organization aims to shorten the timeline from laboratory discovery to clinical application. As it navigates the current landscape of medical innovation, the foundation remains committed to transparency and efficacy, ensuring that every dollar of its $7M is directed toward achieving measurable improvements in patient outcomes and long-term disease management.
See full Crohn's & Colitis Foundation company page
